Paper33501656
A plant-derived TRPV3 inhibitor suppresses pain and itch.
Han Y and 7 others. Br J Pharmacol, 2021. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. A plant-derived TRPV3 inhibitor suppresses pain and itch. Papers, record 33501656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33501656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Plant Preparations | Major topic |
| Pruritus | Major topic |
| TRPV Cation Channels | Major topic |
| Animals | |
| Disease Models, Animal | |
| Mice | |
| Pain | |
| Rutaceae | |
| Skin |
Source PubMed
Grants15
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| KC Wong Education Foundation | Chinese Academy of Sciences | PubMed | ||
| KFJ-STS-SCYD-304 | Chinese Academy of Sciences | PubMed | ||
| XDB31000000 | Chinese Academy of Sciences | PubMed | ||
| Youth Innovation Promotion Association | Chinese Academy of Sciences | PubMed | ||
| ZSTH-034 | Chinese Academy of Sciences | PubMed | ||
| "Light of West China" Program | Chinese Academy of Sciences | PubMed | ||
| 21761142002 | National Natural Science Foundation of China | PubMed | ||
| 31900332 | National Natural Science Foundation of China | PubMed | ||
| 31930015 | National Natural Science Foundation of China | PubMed | ||
| 2019-YT-053 | Science and Technology Department of Yunnan Province | PubMed | ||
| 2019ZF003 | Science and Technology Department of Yunnan Province | PubMed | ||
| 202001AT070121 | Science and Technology Department of Yunnan Province | PubMed | ||
| 202001AW070015 | Science and Technology Department of Yunnan Province | PubMed | ||
| 202003AD150008 | Science and Technology Department of Yunnan Province | PubMed | ||
| 2018YFA0801403 | the Ministry of Science and Technology of China | PubMed |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42589711 | Amelioration of Atopic Dermatitis by Frankincense Oil Extract Is Associated with TRPV3 Regulation and Cutaneous Inflammation Suppression. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589711 | PubMed |
| 42169632 | Mechanisms of pruritus and advances in traditional Chinese medicine therapy (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42169632 | PubMed |
| 41880378 | Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia. | PLoS One | 2026 | https://conductscience.org/library/papers/41880378 | PubMed |
| 41787805 | HaloTag-based approach to quantify subcellular localization of TRPV3 channels. | Biophys J | 2026 | https://conductscience.org/library/papers/41787805 | PubMed |
| 41781621 | A metabolic alarmin from keratinocytes potentiates systemic humoral immunity. | Nature | 2026 | https://conductscience.org/library/papers/41781621 | PubMed |
| 41422779 | Activation of TRPV3 channels in bladder cancer cells stimulates ATP release. | Mol Pharmacol | 2026 | https://conductscience.org/library/papers/41422779 | PubMed |
| 41166019 | Modulatory effects of bioactive natural compounds on pruritic pathways: mechanistic basis and therapeutic prospects. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41166019 | PubMed |
| 41118703 | Physiological functions and pharmacological targeting of transient receptor potential channels. | Pharmacol Rev | 2025 | https://conductscience.org/library/papers/41118703 | PubMed |
| 40831235 | Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product-Based Therapies. | Phytother Res | 2025 | https://conductscience.org/library/papers/40831235 | PubMed |
| 40699677 | Repositioning Fluoxetine as a TRPV3 Channel Inhibitor to Alleviate Skin Inflammation and Pruritus. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699677 | PubMed |
| 40534677 | Proteins from Stressed Mesenchymal Stem Cells Can Repair Hair Follicles and Promote Hair Regeneration. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40534677 | PubMed |
| 40288993 | Activation of transient receptor potential vanilloid 3 is required for keratinocyte differentiation and epidermal barrier formation. | Korean J Physiol Pharmacol | 2025 | https://conductscience.org/library/papers/40288993 | PubMed |
| 40141324 | The Impact of a Quinone Scaffold on Thermo-TRPs Modulation by Dimethylheptyl Phytocannabinoids. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141324 | PubMed |
| 39837134 | TRPV3 in skin thermosensation and temperature responses. | J Physiol Sci | 2025 | https://conductscience.org/library/papers/39837134 | PubMed |
| 39757673 | Advances in the Study for Modulators of Transient Receptor Potential Vanilloid (TRPV) Channel Family. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/39757673 | PubMed |
| 39424975 | Molecular and cellular mechanisms of itch sensation and the anti-itch drug targets. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/39424975 | PubMed |
| 39202808 | Inhibition of Cutaneous TRPV3 Channels by Natural Caffeic Acid for the Alleviation of Skin Inflammation. | Molecules | 2024 | https://conductscience.org/library/papers/39202808 | PubMed |
| 38254707 | Site-Specific Transient Receptor Potential Channel Mechanisms and Their Characteristics for Targeted Chronic Itch Treatment. | Biomolecules | 2024 | https://conductscience.org/library/papers/38254707 | PubMed |
| 38154600 | Selective inhibition of overactive warmth-sensitive Ca2+-permeable TRPV3 channels by antispasmodic agent flopropione for alleviation of skin inflammation. | J Biol Chem | 2024 | https://conductscience.org/library/papers/38154600 | PubMed |
| 38139833 | Targeting Transient Receptor Potential (TRP) Channels, Mas-Related G-Protein-Coupled Receptors (Mrgprs), and Protease-Activated Receptors (PARs) to Relieve Itch. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38139833 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TRPV3 | 162514 | PubTator's text mining | https://conductscience.org/library/genes/162514 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33501656
GET https://conductscience.org/api/papers/v1/33501656/cited_by?page=2